Alx Oncology Holdings (ALXO) Cash & Equivalents Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | 56.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.61% |
| Dec 31, 2025 | -6.80% |
| Sep 30, 2025 | 45.58% |
| Jun 30, 2025 | 24.26% |
| Mar 31, 2025 | 46.81% |
| Dec 31, 2024 | -21.60% |
| Sep 30, 2024 | -17.78% |
| Jun 30, 2024 | -59.16% |
| Mar 31, 2024 | -77.78% |
| Dec 31, 2023 | -54.11% |
| Sep 30, 2023 | -60.08% |
| Jun 30, 2023 | -42.69% |
| Mar 31, 2023 | -60.28% |
| Dec 31, 2022 | -86.58% |
| Sep 30, 2022 | -87.26% |
| Jun 30, 2022 | -83.81% |
| Mar 31, 2022 | -62.99% |
| Dec 31, 2021 | -16.25% |
| Sep 30, 2021 | 48.43% |
| Jun 30, 2021 | 317.89% |
| Dec 31, 2020 | 4,715.56% |